Skip to main content
Premium Trial:

Request an Annual Quote

ABI s Road to VisiGen Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Nov. 7 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 4.

 

1. Looking at 'Anybody Who Would Talk to Us,' ABI Finds VisiGen (Oct. 31)

2. Beckman Coulter Q3 Revenues Grow 2 Percent as Income Drops Nearly 40 Percent (Nov. 2)

3. SeqWright Makes Second Investment in VisiGen; ABI Expected to Start Alliance Before End of Year (Nov. 2)

4. PerkinElmer Obtains $350M Revolving Loan; Cash Could Fund M&A, Alliances (Nov. 1)

5. Nanogen's Revenues Nearly Double in Q3  (Nov. 3)

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.